CN101444303B - Dendrobium kudzu eucommia bark functional food - Google Patents
Dendrobium kudzu eucommia bark functional food Download PDFInfo
- Publication number
- CN101444303B CN101444303B CN2008102337029A CN200810233702A CN101444303B CN 101444303 B CN101444303 B CN 101444303B CN 2008102337029 A CN2008102337029 A CN 2008102337029A CN 200810233702 A CN200810233702 A CN 200810233702A CN 101444303 B CN101444303 B CN 101444303B
- Authority
- CN
- China
- Prior art keywords
- dendrobium
- kudzu
- liver
- eucommia bark
- extractive
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides a dendrobium kudzu eucommia bark functional food, and relates to a health food which can offer auxiliary protection for chemical liver injury and improve immunity, in particular to a health care functional food which takes dendrobium as a monarch drug. The food is prepared by uniformly mixing dendrobium powder with granularity no less than 60 meshes, kudzu extractive with eucommia bark extractive, and the dendrobium powder, the kudzu extractive and the eucommia bark extractive are mixed by the following weight fraction: 6-10 parts of dendrobium, 1-3 parts of kudzu extractive, and 1-2 parts of eucommia bark extractive. The functional food is characterized in that a liver-protective drug which is homology of medicine and food, a drug of nourishing yin and varieties which have the function of tonifying yang are organically combined by a reasonable method to produce a health food with remarkable effects. The functional food has the efficacy of protecting liver, improving eyesight, moistening lung, nourishing stomach, and adjusting the equilibrium between yin and yang in human body, and can achieve the effect of notably improving chemical liver injury and a series of symptoms caused by low immunity.
Description
Technical field
The present invention relates to a kind of health food, the particularly health functional food take the stem of noble dendrobium as monarch drug in a prescription that chemical damage is had assistant protection function and enhancing immunity.
Background technology
Liver is important metabolism organ, all plays an important role at aspects such as the absorption of the materials such as carbohydrate, lipid, protein, vitamin, hormone, bile, storage, bio-transformation, secretion, drainages.Liver has powerful regeneration and compensatory capacity, can overcome slight or limitation damage and the hepatosis that causes.But many causes of disease can cause distortion and the necrosis of liver parenchyma, cause cirrhosis and hepatonecrosis.When liver major injury, metabolic capability significantly weaken, serious hepatosis will appear, and further increase the weight of liver failure, and cause the dysfunction of central nervous system and cause hepatic coma.
The factor that causes hepatic injury is a lot, such as the excessive absorption of alcohol, the erosion that poison and environmental poisonous substance are produced in drug metabolism etc.Claim according to the report of U.S. disease prevention and control center portion in 2004, the U.S. has 7.5 ten thousand people every year dead because of excessive consumption of alcohol.According to another the report in 2004 of the national statistical commission of Russia, there are every year 3.7 ten thousand people of surpassing to die from alcoholism.In recent years, ill crowd's expanding day of alcoholic liver, fatty liver among China resident, and ill crowd presents the trend of becoming younger at the age.Now, the chemical damages such as alcoholic liver, fatty liver have become a kind of common disease, just seriously nibble compatriots healthy.The liver problem is in the urgent need to paying close attention to.Exploitation has the functional food of protection hepatic injury, and market potential is huge.
The health care of China is lain across at all times, and the culture of health preserving of heavily health and integration of drinking and medicinal herbs is just arranged from ancient times.Traditional Chinese medicine is the crystallization of the long-term medical practice of the Chinese nation, and it has with modernized health care sees the similar health care idea that communicates.Advantage with traditional Chinese medicine of the characteristics such as Overall View, diagnosis and treatment, herbal mixture embodies a concentrated expression of the immunity that can adjust in all directions human body, for the high-quality life style of people provides a kind of strong support means.Doctor trained in Western medicine is said " controlling ", the traditional Chinese medical science is said " accent ", " benefit ", " supporting ", clinical treatment means to enhancing immunity are injecting immune globulin, but this only only limits to urgent patient's situation, for general population that can normal life, strengthening immunity does not have any clinical medicine can reach good curative effect substantially.For the symptom of the treatment that suffers for want of medical supplies at present, utilize the Chinese medicine exploitation health food of China's integration of drinking and medicinal herbs, be one and well select.
Show through modern medicine study, body immunity lowly is to cause the unsound immediate cause of liver cell, strengthens body immunity when protecting liver, can effectively strengthen liver function.The present invention fully takes into account this point, utilizes the rare traditional Chinese medicine of medicine-food two-purpose to prepare this functional food, when body immunity is increased, also reaches the effect of liver protecting.
The stem of noble dendrobium: begin to be stated from Shennong's Herbal, classify as top gradely, the successive dynasties book on Chinese herbal medicine is all on the books.The Shennong's Herbal record: " ... distinguish the flavor of sweet, flat, nontoxic.In curing the wound, except numbness, lower gas, the tonifying five zang organs consumptive disease, win thin, reinforcing yin essence.Take for a long time thick stomach, make light of one's life by commiting suicide, prolong life, longue meat, by skin heat symptoms caused by an exopathgen ， Rush gas, sedate is except frightened ... ".Supplementary Amplifications of the Compendium of Materia Medica (clear Zhao Xuemin): " clearing stomach is promoted the production of body fluid except abnormal heat, strain, with for tea, Appetizing spleen-tonifying, wind is treated in arresting convulsion, can press down saliva phlegm, relieving summer-heat, sweet fragrant sending down abnormally ascending ".The stem of noble dendrobium that this product adopts is the dry stem of orchid HERBA DENDROBII Dendrobium nobile lindl.; Be " first-selected kind under stem of noble dendrobium item of Chinese pharmacopoeia (version in 2005).HERBA DENDROBII: one one of the Pharmacopoeia of the People's Republic of China (version in 2005) carries:
[nature and flavor with return through] hardship is slightly cold.Return stomach, kidney channel.
[function with cure mainly] reinforcing stomach reg fluid is nourishing Yin and clearing heat.Be used for the moon and hinder body fluid deficiency, the dry polydipsia, food is few retches, abnormal heat after being ill, order is secretly not clear.
The main product ground of HERBA DENDROBII is born on height above sea level 590～3000 meters original remote mountains woods or the crag in Yunnan.The stem of noble dendrobium is oblate cylindricality, long 20～40cm, straight stem 0.4～0.6cm, the long 2.5～3cm of internode.Surface golden yellow or greenish-yellow look have dark longitudinal furrow.The HERBA DENDROBII main composition is: dendrobium polysaccharide and stem of noble dendrobium alkaloids.Stem of noble dendrobium alkaloids main component has dendrobine (dendrobine), the stem of noble dendrobium time alkali (nobilonine), stem of noble dendrobium ether alkali (dendroxine), 6-hydroxyl stem of noble dendrobium ether alkali, 4-hydroxyl stem of noble dendrobium ether alkali and methine stem of noble dendrobium element (nobilimethylene) etc.Wherein dendrobium polysaccharide is the roborant main component of the stem of noble dendrobium, energy enhanced machine body immunity function, and have antitumor activity.HERBA DENDROBII is among the people in the locality, Yunnan to be to sell as rare traditional Chinese medicine after adopting chip drying or being processed into the maple bucket all the time, but local common people then only use its dry product or fresh goods as tea-drinking.Though its as Chinese medicine and tea-drinking with all being by frying in shallow oil, boil method, the active ingredient of the stem of noble dendrobium can not discharge fully, and fully absorbed by human body, fry in shallow oil, boil by high temperature, the thick polysaccharide of the stem of noble dendrobium becomes oligosaccharides, monose, effect descends, and incorrect and corresponding compatibility of drugs can not be given full play to its effect.
The root of kudzu vine is the dry root of legume pueraria lobata pueraria lobata (Willd.) Ohwi, begins to be stated from Shennong's Herbal, and the successive dynasties book on Chinese herbal medicine is all on the books.Except containing the aspects such as prevention cardiovascular and cerebrovascular are had the flavonoids active component of significant curative effect in the root of kudzu vine, also contain amino acid (lysine, methionine, phenylalanine, isoleucine, leucine etc.) and the trace element (selenium, zinc, manganese, germanium etc.) of needed by human.The root of kudzu vine is to cardiovascular and cerebrovascular, auxiliary antilipemic, hypotensive, auxiliary hyperglycemic, have protective effect, relieve the effect of alcohol, anti-arrhythmia cordis, delay senility, improve learning and memory etc. good effect is arranged chemical damage.The personnel that are particularly useful for chemical damage.For " Chinese pharmacopoeia (version was an one in 2005) is recorded kind.
The root of kudzu vine: one one of the Pharmacopoeia of the People's Republic of China (version in 2005) carries:
[nature and flavor with return through] are sweet, hot, cold.Distinguish the flavor of sweet, return spleen, stomach warp.
[function with cure mainly] relieving muscles to expel heat promotes the production of body fluid, and promoting eruption rises positive stopping leak.Be used for fever caused by exogenous pathogens headache, stiff nape and back, thirsty, quench one's thirst, measles without adequate eruption, hot dysentery is had loose bowels; The hypertension neck pain.
Folium cortex eucommiae: be the dry leaf of Eucommiaceae plant bark of eucommia Eucommia ulmoides Oliv..The bark of eucommia is the famous and precious tonic Chinese herbal medicine material of China, just is listed in product on the medicine in Shennong's Herbal, Compendium of Material Medica.In recent years, domestic and international many scholars have carried out large quantity research to chemical composition and the pharmacological action of folium cortex eucommiae, find that folium cortex eucommiae and the bark of eucommia have similar chemical composition, all have the liver of protecting, strengthen immunity, regulate blood fat, reduce blood sugar, regulate blood pressure, the pharmacological action such as antibiotic, antiviral, inhibition tumor cell growth, and delay senility, the effects such as beauty face-whitening-nourishing, enriching yin and nourishing kidney, strong muscles and bones.
Xin Xiaoming etc. studies show that, cortex eucommiae total polyoses can obviously suppress endoxan and cause hepatic injury mice serum paddy the third transaminase (ALT), the excessive generation of the peroxide MDA (MDA) of the rising of millet straw transaminase (AST) and hepatic tissue, impaired liver superoxide dismutase (SOD) activity also significantly raises, this is conducive to remove free radical, reduce the peroxidating of membrane lipid, its hepatic injury that endoxan is caused has good therapeutic action, for the therapy of combing traditional Chinese and Western medicine of tumour provides experimental basis, both interactional mechanism remain further research.Peng Mijun etc. utilize the High Performance Liquid Chromatography/Mass Spectrometry method to measure iridoid content in the Eucommia Samples, prove in the leaf, skin of the bark of eucommia to contain similar chemical composition, are mainly iridoids, Phenylpropanoid Glycosides class, flavonoids etc.Different iridoid compound drug activities are different.Aucubin has the hepatic cholagogic effect, can protect CC1
4The hepatic injury of inducing; That Geniposidic acid then has is anti-aging, promote collagen synthesis and improve the cuticula metabolic function of the mouse that grows up; And geniposide has the effects such as the interior antithrombotic of body.
Folium cortex eucommiae: one one of the Pharmacopoeia of the People's Republic of China (version in 2005) carries:
[nature and flavor with return through] little suffering, temperature.Return liver, kidney channel.
[function with cure mainly] filling liver kidney, strengthening the bones and muscles.Be used for kidney deficiency and liver, have a dizzy spell, soreness of waist and knee joint, the muscles and bones impotence is soft.
Summary of the invention
Technical problem to be solved by this invention provides a kind of dendrobium kudzu eucommia bark functional food, has the health-care efficacy that significantly protects liver, enhancing immunity, strengthens resistance against diseases, and is without any side effects.
Solving the scheme that technical problem of the present invention adopts is: mixed and formed by granularity 〉=60 purpose stem of noble dendrobium powder, kudzu root extract, eucommia ulmoides extracts, and the ratio of three's mixed weight mark is: 6～10 parts of the stems of noble dendrobium, 1～3 part of kudzu root extract, 1～2 part of eucommia ulmoides extracts.In this prescription, eucommia ulmoides extracts is the extract of folium cortex eucommiae, and the stem of noble dendrobium adopts HERBA DENDROBII, can reach better efficacy, the effect that cost is lower.
Compatibility foundation of the present invention: take the stem of noble dendrobium as monarch drug in a prescription, assistant is with the root of kudzu vine and folium cortex eucommiae compatibility.Stem of noble dendrobium flavor is sweet, nourishing hepatic yin; Folium cortex eucommiae is returned liver, kidney channel, liver-kidney tonifying; Root of kudzu vine flavor cool in nature is sweet, and clearing heat and promoting fluid is induced sweat.Full side cooperates, and sweet profit is gentle, enriching yin Yiyang, and treating YANG within YIN, then positive that the cloudy biochemistry that helps is infinite, treating YIN within YANG, then YIN matched with sufficient YANG making living things fully vivid; Again flat liver purge heat, sending up the lucid yang, the body functional state of transferring person altogether, thereby strengthening vital QI to eliminate pathogenic factors strengthen resistance against diseases, transfer the defense function of human body integral, amount to the purpose of liver protecting.Immunocompromised person and fatiguability person there is good health-care efficacy.
The invention has the beneficial effects as follows: the functional food that adopts the stem of noble dendrobium, the root of kudzu vine, folium cortex eucommiae to produce, easy to use, can give full play to the effect of the stem of noble dendrobium, and mutually collaborative with the root of kudzu vine and folium cortex eucommiae, has higher active component, it is more remarkable for the health-care effect of chemical damage person, immunocompromised person's symptom specially, has no side effect.And the significant composition/functional component of food of the present invention is clear and definite, and steady quality meets the requirement of large production.
Aspect the protection of chemical damage: the effect of lipid peroxide catabolite MDA (MDA) content in the hepatic tissue of reduction Alcoholic damage; The effect of triglyceride (TG) content in the hepatic tissue of reduction Alcoholic damage; Improve the effect of reduced glutathione (GSH) content in the hepatic tissue; Alleviate the effect of the hepatic tissue steatosis of alcoholic liver injury in rats.
Aspect enhancing immunity: promote spleen lymphocyte proliferation, transformation; Enhancing antibody cellulation propagation; Improve serum and melt the sanguinin level; Promote monocytes/macrophages carbon to clean up the phagocytic activity of function and peritoneal macrophage; Improve NKT (NK) cytoactive.
The specific embodiment
Embodiment 1: medicine of the present invention is comprised of following component: (weight proportion)
Main component: 6 parts of the stems of noble dendrobium, 1 part of kudzu root extract, 1 part of eucommia ulmoides extracts.
The preparation method step:
Step 1: stem of noble dendrobium crushed after being dried, mistake 60 mesh sieves, get powder;
Step 2: cross 60 mesh sieves after stem of noble dendrobium powder, kudzu root extract, eucommia ulmoides extracts mix, with the amount capsule charge of 0.2g.
Embodiment 2: medicine of the present invention is comprised of following component: (weight proportion)
Main component: 6 parts of the stems of noble dendrobium, 2 parts of kudzu root extracts, 2 parts of eucommia ulmoides extracts;
Preparation method step: with embodiment 1.
Embodiment 3: medicine of the present invention is comprised of following component: (weight proportion)
Main component: 7 parts of the stems of noble dendrobium, 2 parts of kudzu root extracts, 1 part of eucommia ulmoides extracts;
Preparation method step: with embodiment 1.
Embodiment 4: medicine of the present invention is comprised of following component: (weight proportion)
Main component: 7 parts of the stems of noble dendrobium, 1 part of kudzu root extract, 2 parts of eucommia ulmoides extracts.
Preparation method step: with embodiment 1.
Above-described embodiment is used for chemical damage is had the functional food of assistant protection function and enhancing immunity, through general preparation process, can make multiple formulation, such as capsule, tablet, powder, electuary, paste or granule.
The result of function test of the present invention:
The capsule that adopts above-described embodiment 1 prescription to make carries out function test and evaluation of test result according to the regulation of Ministry of Public Health's " health food check and assessment technique standard (2003 editions) ".
One, chemical damage there is the assistant protection function result of the test
1, sample is on the impact of rat body weight
Respectively organize rat body weight before and after table 1 test and change (X ± S)
| Dosage group (mg/kg BW) | Number of animals (only) | Before the test (g) | The first weekend (g) | The second weekend (g) | The 3rd weekend (g) | The 30th day (g) | Gain in weight (g) |
| 800 | 12 | 257.0±38.2 | 268.1±42.8 | 281.3±43.1 | 298.4±46.3 | 314.2±53.4 | 57.2±22.4 |
| 400 | 12 | 259.2±28.3 | 267.8±32.7 | 280.3±36.1 | 296.8±36.2 | 316.3±41.9 | 57.1±18.2 |
| 200 | 12 | 257.3±25.0 | 267.6±26.3 | 280.0±26.9 | 292.3±24.6 | 306.1±36.8 | 48.8±16.4 |
| The model contrast | 12 | 255.2±29.2 | 272.9±30.2 | 289.8±31.5 | 298.0±32.8 | 328.3±42.2 | 73.2±19.3 |
| Negative control | 12 | 262.7±32.9 | 267.8±29.8 | 289.2±41.8 | 305.3±42.7 | 322.1±42.1 | 59.4±17.0 |
Annotate: in the table between each group comparing difference there are no significant (P〉0.05).
By as seen from Table 1, respectively organize rat body weight before the test consistent, gain in weight when respectively organizing the body weight of rat and off-test each week of process of the test compares mutually, and difference does not all have conspicuousness (P〉0.05), shows that this sample does not have obvious influence to the body weight gain of rat.
2, sample is on the impact of hepatic tissue lipid peroxide catabolite MDA (MDA) content of alcoholic liver injury in rats
Table 2 is respectively organized liver tissues of rats homogenate MDA (MDA) content (X ± S)
| Dosage group (mg/kg BW) | Number of animals (only) | Liver MDA (nmol/g hepatic tissue) | The P value |
| 800 | 12 | 123.8±27.1 | 0.158 |
| 400 | 12 | 112.5±20.4 | 0.011 |
| 200 | 12 | 117.6±17.8 | 0.026 |
| The model contrast | 12 | 140.0±27.3 | ...... |
| Negative control | 12 | 106.9±15.3 | 0.002 |
Annotate: the P value is each group and model control group statistics relatively in the table
As seen from Table 2, liver decreases the MDA content of model control group liver tissues of rats apparently higher than negative control group, and both difference has very significant (P＜0.01), illustrate that liver decreases the model establishment.The MDA content of each dosage group liver tissues of rats of sample all is lower than liver and decreases model control group, and in, the difference of low dose group and model control group all has conspicuousness (P＜0.05), shows that this sample has the effect of LPO in the hepatic tissue that reduces the Alcoholic damage.
3, sample is on the impact of hepatic tissue triglycerides (TG) content of alcoholic liver injury in rats
Table 3 is respectively organized liver tissues of rats homogenate TG content (X ± S)
| Dosage group (mg/kg BW) | Number of animals (only) | Hepatic tissue TG content (mmol/100g hepatic tissue) | The P value |
| 800 | 12 | 2.43±0.36 | 0.020 |
| 400 | 12 | 2.52±0.42 | 0.020 |
| 200 | 12 | 2.50±0.50 | 0.020 |
| The model contrast | 12 | 4.10±2.06 | .... |
| Negative control | 12 | 1.23±0.93 | 0.020 |
Annotate: the P value is each group and model control group statistics relatively in the table
As seen from Table 3, liver decreases the hepatic tissue TG content of model control group apparently higher than negative control group, and both differences have very significant (P＜0.01), illustrates that liver decreases model and sets up.The hepatic tissue TG content of each dosage group of sample all is lower than liver and decreases model control group, and all have very significant (P＜0.05) with the difference of model control group, show that this sample has the effect of triglyceride (TG) content in the hepatic tissue that reduces the Alcoholic damage.
4, sample is on the impact of hepatic tissue reduced glutathione (GSH) content of alcoholic liver injury in rats
Table 4 is respectively organized liver tissues of rats homogenate GSH content (X ± S)
| Dosage group (mg/kg BW) | Number of animals (only) | Hepatic tissue GSH content (μ mol/g hepatic tissue) | The P value |
| 800 | 12 | 11.4±1.5 | 0.015 |
| 400 | 12 | 11.5±1.2 | 0.008 |
| 200 | 12 | 11.0±1.2 | 0.034 |
| The model contrast | 12 | 9.4±2.1 | .... |
| Negative control | 12 | 11.8±1.8 | 0.007 |
Annotate: the P value is each group and model control group statistics relatively in the table
As seen from Table 4, GSH content significantly is lower than negative control group in the hepatic tissue of liver damage model control group, and both differences have very significant (P＜0.01), shows that liver decreases model and sets up.The GSH content of each dosage group liver tissues of rats of sample and model control group compare, and difference all has conspicuousness (P＜0.05), shows that this sample is to the GSH content effect of having a significant effect in the hepatic tissue of alcoholic liver injury in rats.
5, sample is on the impact of the hepatic tissue steatosis of alcoholic liver injury in rats
Table 5 is respectively organized liver tissues of rats steatosis check result (X ± S)
| Dosage group (mg/kg BW) | Number of animals (only) | Tissue fat sex change scoring | The P value |
| 800 | 12 | 206.1±65.5 | 0.000 |
| 400 | 12 | 137.6±96.8 | 0.000 |
| 200 | 12 | 129.4±53.1 | 0.000 |
| The model contrast | 12 | 76.8±63.6 | .... |
| Negative control | 12 | 268.1±7.17 | 0.000 |
Annotate: the P value is each group and model control group statistics relatively in the table
As seen from Table 5, the hepatic tissue steatosis score value that liver decreases the model control group rat is higher than negative control group, and both differences have very significant (P＜0.01), shows that liver decreases model and sets up.Each dosage group liver tissues of rats steatosis score value of sample all is lower than liver and decreases model control group, and have conspicuousness (P＜0.01) with the difference of model control group, show that this sample has the effect of the hepatic tissue steatosis that alleviates alcoholic liver injury in rats.
Brief summary: per os gives rat 200mg/kg BW, 400mg/kg BW, 800mg/kg BW (be equivalent to human body and recommend consumption 5,10,20 times) the dendrobium kudzu eucommia bark capsule of dosage, give the continuous gavage of rat 30 days, can significantly reduce MDA (MDA), triglycerides (TG) content in the liver tissues of rats that alcoholic liver decreases model and improve reduced glutathione (GSH) content in the hepatic tissue, alleviate hepatic tissue steatosis degree, the body weight of rat is had no significant effect.This shows, this sample has has the assistant protection function effect to alcoholic liver injury.Can prove from above-mentioned model, this sample has assistant protection function to hepatic injury.
Two, strengthen the function test result of immunity
1, sample is on the impact of Mouse Weight
Table 1 dendrobium kudzu eucommia bark capsule strengthens immunity function test mice body weight, and (x ± s) immune I organizes (the mouse spleen lymphocyte transformation experiment that ConA induces, NK cytoactive detection)
| Dosage group (mg/kg BW) | Number of animals (only) | Initial body weight (g) | Body weight in mid-term (g) | Body weight in latter stage (g) | Weightening finish (g) |
| 800 | 12 | 20.7±1.0 | 29.2±1.6 | 35.3±2.1 | 14.6±2.1 |
| 400 | 12 | 20.5±1.0 | 28.9±1.8 | 35.1±1.9 | 14.5±2.2 |
| 200 | 12 | 20.8±0.9 | 29.2±1.6 | 35.4±2.4 | 15.1±2.1 |
| Negative control | 12 | 20.7±1.0 | 29.3±1.6 | 35.9±2.4 | 15.3±2.3 |
Annotate: each dosage group experiment is initial, Mouse Weight and the weightening finish and control group comparison in mid-term and latter stage, there are no significant for difference (P〉0.05).
Table 2 dendrobium kudzu eucommia bark capsule strengthens immunity function test mice body weight, and (x ± s) immune II organizes (carbon is cleaned up experiment)
| Dosage group (mg/kg BW) | Number of animals (only) | Initial body weight (g) | Body weight in mid-term (g) | Body weight in latter stage (g) | Weightening finish (g) |
| 800 | 12 | 20.1±0.6 | 29.2±1.6 | 34.8±1.4 | 14.7±1.8 |
| 400 | 12 | 20.2±0.8 | 28.9±1.9 | 35.3±1.6 | 14.8±1.2 |
| 200 | 12 | 20.1±0.8 | 29.2±2.2 | 34.4±2.2 | 14.6±2.2 |
| Negative control | 12 | 20.2±0.6 | 29.3±2.0 | 35.4±2.0 | 14.1±1.7 |
Immunity III group (dirty/the body ratio measurement, serum hemolysin is measured and the antibody-producting cell number is measured)
| Dosage group (mg/kg BW) | Number of animals (only) | Initial body weight (g) | Body weight in mid-term (g) | Body weight in latter stage (g) | Weightening finish (g) |
| 800 | 12 | 20.1±0.6 | 27.2±1.6 | 34.3±1.4 | 14.5±2.1 |
| 400 | 12 | 20.2±0.8 | 27.9±1.4 | 35.1±1.6 | 14.4±1.5 |
| 200 | 12 | 20.1±0.8 | 28.2±1.6 | 34.4±2.2 | 15.1±2.1 |
| Negative control | 12 | 20.2±0.6 | 28.3±2.6 | 35.9±2.0 | 14.6±1.7 |
Immunity IV group (delayed allergy experiment)
| Dosage group (mg/kg BW) | Number of animals (only) | Initial body weight (g) | Body weight in mid-term (g) | Body weight in latter stage (g) | Weightening finish (g) |
| 800 | 12 | 20.2±0.4 | 28.9±1.5 | 34.7±2.3 | 14.5±2.3 |
| 400 | 12 | 20.3±0.6 | 29.1±1.1 | 34.8±1.6 | 14.6±1.7 |
| 200 | 12 | 20.3±0.8 | 29.2±0.8 | 34.8±1.5 | 14.5±1.3 |
| Negative control | 12 | 20.4±1.8 | 28.3±1.2 | 35.6±1.8 | 15.3±1.8 |
Immunity V group (Turnover of Mouse Peritoneal Macrophages is engulfed the chicken red blood cell experiment)
| Dosage group (mg/kg BW) | Number of animals (only) | Initial body weight (g) | Body weight in mid-term (g) | Body weight in latter stage (g) | Weightening finish (g) |
| 800 | 12 | 20.4±1.0 | 28.3±1.2 | 34.9±2.0 | 14.5±2.0 |
| 400 | 12 | 20.4±1.0 | 29.3±2.1 | 35.9±2.1 | 15.5±2.0 |
| 200 | 12 | 20.3±0.9 | 28.5±1.6 | 34.4±2.3 | 14.1±2.4 |
| Negative control | 12 | 20.5±1.0 | 29.0±2.3 | 34.9±2.2 | 14.4±1.8 |
Annotate: each dosage group experiment is initial, Mouse Weight and the weightening finish and control group comparison in mid-term and latter stage, there are no significant for difference (P〉0.05).
By table 1, as seen from Table 2, test between first, as to test mid-term, experiment each dosage group of sample in latter stage Mouse Weight and experimental session weight of mice and negative control group and compare, there are no significant for difference (P〉0.05), show that this sample has no significant effect the body weight gain of mouse.
2, sample is on the impact of mouse immune organ internal organs/body weight ratio
The immune organ internal organs of table 3 dendrobium kudzu eucommia bark capsule enhancing immunity function test mice/body weight ratio (x ± s)
| Dosage group (mg/kg BW) | Number of animals (only) | Number thymus gland/body weight (%) | The P value | Spleen/body weight (%) | The P value |
| 800 | 12 | 0.273±0.034 | 1.000 | 0.443±0.044 | 0.815 |
| 400 | 12 | 0.256±0.024 | 0.589 | 0.430±0.058 | 1.000 |
| 200 | 12 | 0.271±0.065 | 0.995 | 0.437±0.044 | 0.967 |
| Negative control | 12 | 0.274±0.027 | --- | 0.430±0.024 | --- |
By as seen from Table 3, per os gives the dendrobium kudzu eucommia bark capsule 30 days of mouse various dose, thymus gland/body weight of mouse and spleen/body weight ratio and negative control group compare, and difference that there are no significant (P〉0.05), show that this sample has no significant effect the immune organ weight of mouse.
3, sample is on the impact of the cellular immunity of mouse
3.1 the impact of the mouse spleen lymphocyte conversion capability that sample is induced ConA
The mouse lymphocyte transformation experiment result of table 4 dendrobium kudzu eucommia bark capsule (the official's internal organs/body weight ratio of x ± s) (x ± s)
| Dosage group (mg/kg BW) | Number of animals (only) | Lymphopoiesis ability (OD value) | The P value |
| 800 | 12 | 1.606±1.301 | 0.001 |
| 400 | 12 | 0.768±0.206 | 0.431 |
| 200 | 12 | 0.550±0.161 | 0.918 |
| Negative control | 12 | 0.407±0.308 | --- |
As seen from Table 4, per os gives the dendrobium kudzu eucommia bark capsule 30 days of mouse various dose, the lymphocyte transformation ability of high dose group mouse is apparently higher than negative control group, difference has conspicuousness (P＜0.01), shows that this sample has the lymphopoiesis that promotes mouse, the effect of conversion capability.
3.2 sample is on the impact of mouse delayed allergy (DTH)
Mouse delayed allergy (DTH) experimental result of table 5 dendrobium kudzu eucommia bark capsule (x ± s)
| Dosage group (mg/kg BW) | Number of animals (only) | Left and right sides auricle weight difference (mg) | The P value |
| 800 | 12 | 11.63±2.26 | 0.089 |
| 400 | 12 | 11.25±2.74 | 0.197 |
| 200 | 12 | 10.50±2.34 | 0.639 |
| Negative control | 12 | 9.57±1.87 | --- |
As seen from Table 5, per os gives the dendrobium kudzu eucommia bark capsule 30 days of mouse various dose, the left and right sides auricle weight difference of high, middle low dose group mouse is higher than negative control group, but there was no significant difference (P〉0.05), show that this sample does not promote the effect of delayed allergy.
4, sample is on the impact of the humoral immunity of mouse
4.1 sample is on the impact of the antibody-producting cell number of mouse
As seen from Table 6, per os gives the dendrobium kudzu eucommia bark capsule 30 days of mouse various dose, the antibody-producting cell number of high dose group mouse is higher than negative control group, and two groups of differences have conspicuousness (P＜0.05), shows that this sample has the effect that promotes mouse antibodies cellulation propagation.
The antibody-producting cell test experience result of table 6 dendrobium kudzu eucommia bark capsule (x ± s)
| Dosage group (mg/kg BW) | Number of animals (only) | Hemolysis plaque number (1 * 10 3/ full spleen) | The P value |
| 800 | 12 | 227.50±26.65 | 0.042 |
| 400 | 12 | 216.83±21.41 | 0.338 |
| 200 | 12 | 210.25±29.45 | 0.755 |
| Negative control | 12 | 202.00±30.00 | --- |
4.2 sample is on the impact of mice serum hemolysin
The mouse hemolysin test result of table 7 dendrobium kudzu eucommia bark capsule (x ± s)
| Dosage group (mg/kg BW) | Number of animals (only) | The antibody product | The P value |
| 800 | 12 | 166.25±18.96 | 0.001 |
| 400 | 12 | 161.75±16.35 | 0.002 |
| 200 | 12 | 154.33±20.29 | 0.029 |
| Negative control | 12 | 134.83±15.87 | --- |
As seen from Table 7, per os gives the dendrobium kudzu eucommia bark capsule 30 days of mouse various dose, the antibody product of high, medium and low dosage group mouse is higher than negative control group, and all have conspicuousness (respectively P＜0.01 and P＜0.05) with the difference of negative control group, show that this sample has the effect of the serum hemolysin that improves mouse.
5, sample is on the impact of the monocytes/macrophages phagocytic function of mouse
5.1 the impact that sample is cleaned up the monocytes/macrophages carbon of mouse
The mouse carbon of table 8 dendrobium kudzu eucommia bark capsule is cleaned up experimental result (x ± s)
| Dosage group (mg/kg BW) | Number of animals (only) | Phagocytic index | The P value |
| 800 | 12 | 10.72±1.41 | 0.001 |
| 400 | 12 | 9.95±1.53 | 0.007 |
| 200 | 12 | 8.61±1.60 | 0.675 |
| Negative control | 12 | 8.06±1.22 | --- |
As seen from Table 8, per os gives the dendrobium kudzu eucommia bark capsule 30 days of mouse various dose, the phagocytic index of high, middle dosage group mouse is higher than negative control group, have conspicuousness (P＜0.01) with the difference of negative control group, show that this sample has the effect that the monocytes/macrophages carbon that promotes mouse is cleaned up function.
5.2 sample is engulfed the impact of chicken red blood cell ability on the peritoneal macrophage of mouse
The Turnover of Mouse Peritoneal Macrophages of table 9 dendrobium kudzu eucommia bark capsule is engulfed chicken red blood cell experimental result (x ± s)
| Dosage group (mg/kg BW) | Number of animals (only) | Phagocytic rate (%) | The phagocytic index data transaction | The P value | Phagocytic index | The P value |
| 800 | 12 | 47.42±13.17 | 0.762±0.142 | 0.001 | 0.854±0.394 | 0.001 |
| 400 | 12 | 38.42±9.73 | 0.667±0.100 | 0.007 | 0.756±0.284 | 0.011 |
| 200 | 12 | 28.33±9.12 | 0.559±0.096 | 0.760 | 0.514±0.192 | 0.637 |
| Negative control | 12 | 24.92±8.98 | 0.519±0.098 | --- | 0.398±0.239 | --- |
As seen from Table 9, per os gives the dendrobium kudzu eucommia bark capsule 30 days of mouse various dose, the peritoneal macrophage of each dosage group mouse of sample all is higher than negative control group to phagocytic rate and the phagocytic index of chicken red blood cell, the difference of the phagocytic rate of height wherein, middle dosage group and phagocytic index and control group has conspicuousness (P＜0.01 or P＜0.05), shows that this sample has the effect of the Peritoneal Macrophage Phagocytosis that promotes mouse.
6, sample is on the impact of the NK cytoactive of mouse
The NK cells in mice determination of activity result of table 10 dendrobium kudzu eucommia bark capsule (x ± s)
| Dosage group (mg/kg BW) | Number of animals (only) | NK cytoactive (%) | NK cytoactive data transaction | The P value |
| 800 | 12 | 59.61±13.10 | 0.887±0.143 | 0.001 |
| 400 | 12 | 41.37±10.23 | 0.697±0.104 | 0.001 |
| 200 | 12 | 28.81±8.17 | 0.562±0.094 | 0.003 |
| Negative control | 12 | 14.20±12.86 | 0.360±0.174 | --- |
As seen from Table 10, per os gives the dendrobium kudzu eucommia bark capsule 30 days of mouse various dose, the NK cytoactive of each dosage group mouse of sample all is higher than negative control group, and the difference of each dosage group and negative control group has very significant (P＜0.01), shows that this sample has the effect of the NK cytoactive that improves mouse.
Brief summary: per os gives mouse 200mg/kg BW, 400mg/kg BW, 800mg/kg BW (is equivalent to human body and recommends consumption 5,10,20 times) the dendrobium kudzu eucommia bark capsule of dosage 30 days, can promote the spleen lymphocyte proliferation of mouse, transformation, promote the antibody-producting cell propagation of mouse, improve the serum hemolysin of mouse, promote the monocytes/macrophages carbon of mouse to clean up the phagocytic activity of function and peritoneal macrophage, improve the NK cytoactive of mouse, body weight gain to mouse, thymus gland/body weight ratio, spleen/body weight ratio has no significant effect, and points out this sample to have the function that strengthens immunity.
Claims (1)
1. dendrobium kudzu eucommia bark functional food, it is characterized in that: mixed by granularity 〉=60 purpose HERBA DENDROBII powder and kudzu root extract and eucommia leaf extract and form, the ratio of mixed weight mark is: 6～10 parts of the stems of noble dendrobium, 1～3 part of kudzu root extract, 1～2 part of eucommia leaf extract.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008102337029A CN101444303B (en) | 2008-12-10 | 2008-12-10 | Dendrobium kudzu eucommia bark functional food |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008102337029A CN101444303B (en) | 2008-12-10 | 2008-12-10 | Dendrobium kudzu eucommia bark functional food |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101444303A CN101444303A (en) | 2009-06-03 |
| CN101444303B true CN101444303B (en) | 2013-04-03 |
Family
ID=40740416
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2008102337029A Expired - Fee Related CN101444303B (en) | 2008-12-10 | 2008-12-10 | Dendrobium kudzu eucommia bark functional food |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101444303B (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101653249B (en) * | 2009-09-03 | 2012-08-08 | 陶国闻 | Functional food capable of lowering blood sugar and enhancing immunity |
| CN101810330B (en) * | 2010-04-19 | 2012-09-19 | 奉化益珍海藻科技有限公司 | Manufacture method of enteromorpha clathrata-dendrobium refined flour |
| CN102318823B (en) * | 2011-10-07 | 2012-07-25 | 刘和勇 | Dendrobium nobile nutritive powder |
| CN103238798B (en) * | 2013-05-17 | 2015-04-22 | 绍兴儒林生物科技有限公司 | Dendrobium nutrient tablet and preparation method |
| CN104509620A (en) * | 2014-12-11 | 2015-04-15 | 罗生芳 | Herbal tea containing eucommia folium and preparation method thereof |
| CN104872713A (en) * | 2015-05-27 | 2015-09-02 | 安徽先知缘食品有限公司 | Dendrobium nobile and kudzu vine root duck gizzard and preparation method thereof |
| CN108936630A (en) * | 2018-08-07 | 2018-12-07 | 九仙尊霍山石斛股份有限公司 | A kind of Dendrobidium huoshanness turmeric radix puerariae capsule and preparation method |
-
2008
- 2008-12-10 CN CN2008102337029A patent/CN101444303B/en not_active Expired - Fee Related
Non-Patent Citations (2)
| Title |
|---|
| 吴晓冰等.《解酒醒酒与护肝养胃》.《解酒醒酒与护肝养胃》.金盾出版社,2007, * |
| 张康健等.《风靡全球的杜仲健康新理念》.《风靡全球的杜仲健康新理念》.西北农林科技大学,2005, * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101444303A (en) | 2009-06-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104435775B (en) | A kind of Traditional Chinese medicinal health-care wine and preparation method thereof | |
| CN101695376B (en) | Health-care food for preventing diabetes | |
| CN102907604B (en) | Health-care product having effects of reducing blood sugar and pressure, losing weight, relaxing bowels, maintaining beauty and resisting fatigue and production process thereof | |
| CN101444303B (en) | Dendrobium kudzu eucommia bark functional food | |
| CN109007808A (en) | A kind of relieving alcoholism and protecting liver composition and the relieving alcoholism and protecting liver preparation comprising it | |
| CN106666312A (en) | Health-care food for assisting blood glucose decreasing and preparation method of granule and capsule thereof | |
| CN103099089A (en) | Health-care product for reducing blood sugar and blood pressure, relaxing bowels, losing weight, resisting fatigue and improving sexual function and production technology thereof | |
| CN102526479B (en) | Health-care medicine formula with functions of enhancing immunity and lowering blood sugar | |
| CN109222100A (en) | A kind of ginseng Cordyceps militaris composition, ginseng Cordyceps militaris pressed candy and preparation method thereof | |
| CN107156828A (en) | A kind of full nutrition formula food suitable for patients with inflammatory bowel | |
| CN105454576A (en) | Jasmine-flower-comprising assorted Chinese herbal tea and preparation method thereof | |
| CN105010669A (en) | Refreshing and moistening health-care jasmine flower tea and production method thereof | |
| CN101305801A (en) | Dendrobium nobile American ginseng capsule | |
| CN101946895B (en) | Functional food taking loach as main material and preparation method thereof | |
| CN106176953A (en) | A kind of Hyperglycemic health care compositions comprising leaf of Cyclocarya paliurus Iljinskaja, Fructus Momordicae and Folium Mori | |
| CN106177183A (en) | A kind of Hyperglycemic health care compositions comprising leaf of Cyclocarya paliurus Iljinskaja, green tea and Folium Mori | |
| CN106177053A (en) | A kind of Hyperglycemic health care compositions comprising leaf of Cyclocarya paliurus Iljinskaja and Pericarpium Citri Reticulatae | |
| CN104223297B (en) | A kind of schisandra chinensis health-care oral liquid of slow down aging and preparation method thereof | |
| CN109395028A (en) | A kind of Ge Jingjia ginseng wine formula and preparation method preventing, treating three high diseases | |
| CN101708306B (en) | Chinese medicinal composition for treating gastropathy and preparation method thereof | |
| CN106177477A (en) | A kind of health composition for blood sugar lowering, blood fat reducing and blood pressure lowering | |
| CN108813465A (en) | A kind of fig function chewable tablets and preparation method thereof | |
| CN108813501A (en) | With the relieving cough and reducing sputum health honey paste relievingd asthma and adjust function of human body of clearing heat and moistening lung | |
| CN106177432A (en) | A kind of health composition comprising leaf of Cyclocarya paliurus Iljinskaja, Folium Mori, green tea and Rhizoma Polygonati Odorati | |
| CN105125946A (en) | Gardenia oral liquid clearing away heart fire and relieving restlessness and preparing method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: WANG JING Free format text: FORMER OWNER: TAO GUOWEN Effective date: 20141119 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C53 | Correction of patent for invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Wang Jing Inventor before: Tao Guowen |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 650106 KUNMING, YUNNAN PROVINCE TO: 650000 KUNMING, YUNNAN PROVINCE Free format text: CORRECT: INVENTOR; FROM: TAO GUOWEN TO: WANG JING |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20141119 Address after: 650000 No. 7, Donghua 30, Donghua District, Guandu District, Yunnan, Kunming Patentee after: Wang Jing Address before: 650106 Yunnan city of Kunming province high tech Zone Haiyuan Road No. 6 building nine floor high tech investment Patentee before: Tao Guowen |
|
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130403 Termination date: 20191210 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |